GILDER GAGNON HOWE & CO LLC - TALON THERAPEUTICS CVR NEW ownership

Back to all holdings Add to watchlist

TALON THERAPEUTICS CVR NEW's ticker is and the CUSIP is 874CNT108. A total of 1 filers reported holding TALON THERAPEUTICS CVR NEW in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of TALON THERAPEUTICS CVR NEW
ValueSharesWeighting
Q2 2023$0–1250.0%0.00%–
Q4 2021$0–1250.0%0.00%–
Q3 2021$0–1250.0%0.00%–
Q2 2021$0–1250.0%0.00%–
Q1 2021$0–1250.0%0.00%–
Q4 2020$0–1250.0%0.00%–
Q3 2020$0–1250.0%0.00%–
Q2 2020$0–1250.0%0.00%–
Q1 2020$0–1250.0%0.00%–
Q4 2019$0–1250.0%0.00%–
Q3 2019$0–125–0.00%–
 Download
Other shareholders
TALON THERAPEUTICS CVR NEW shareholders Q2 2023
NameSharesValueWeighting ↓
GILDER GAGNON HOWE & CO LLC 125$00.00%
View complete list of TALON THERAPEUTICS CVR NEW shareholders